U.S. SECURITIES AND EXCHANGE COMMISSION
     Washington, D.C. 20549

                         FORM 10-QSB

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2000

     OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File Number 01-8929

               SANITARY ENVIRONMENTAL MONITORING LABS, INC.
_________________________________________________________________
(Exact name of small business issuer as specified in its charter)

         Nevada                            13-3432594
(State or other jurisdiction of         (I.R.S. Employer
 incorporation or organization)         Identification No.)

  1408 Pawnee Drive, Las Vegas, Nevada          89102
(Address of principal executive offices)      (Zip Code)

                    (888) 355-8805
  (Issuer's telephone number, including area code)

              N/A

(Former name, former address and former fiscal year, if changed
since last report)

Check whether the Issuer (1) filed all reports required to be
filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.     Yes __   No  X

The number of shares outstanding of the Issuer's Common Stock,
its sole class of equity, was 9,603,827 as of June 30, 2000.

Part 1

Item 1.  FINANCIAL STATEMENTS

                 SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                      (A Development Stage Company)
                                 UNAUDITED
                              BALANCE SHEETS
                     June 30, 2000 and June 30, 1999

                                  ASSETS

                                        June 30,      June 30,
                                          2000          1999

Current Assets
 Cash                                     $ 62,460         721
 Accounts Receivable                             0           0
 Other Receivable                                0           0
 Inventories/Supplies                       67,914           0
 Pre-paid expenses                               0           0

     Total Current Assets                $ 130,374         721

Fixed Assets                                     0           0
 Less Accumulated Depreciation                   0           0

     Total Fixed Assets                          0         721
                                          --------      ------
     Total Assets                        $ 130,374         721
                                          ========      ======

                                  LIABILITIES

Current Liabilities
 Accounts Payable                         $ 17,637   $  20,354
 Notes Payable                              14,026           0
 Litigation Reserve Payable                 65,000           0
 Due to Related Party (Note 5)           1,113,855      72,096
 Accrued Salaries                                0           0
                                           -------    --------
     Total Current Liabilities          $1,210,518    $ 92,450

Long-Term Liabilities                            0           0
                                         ---------   ---------
     Total Long-Term Liabilities                 0           0

Stockholders' Deficit
 Common Stock, $.001 par value,
  authorized 50,000,000 shares,
  issued and outstanding
  2,553,827 in 1999 and 9,603,827           25,538      25,538
 Additional Paid-In Capital              7,984,901   7,777,260
 Accumulated Deficit During
   The Development Stage                (8,095,670) (7,884,958)

 Net Income                               (994,912)         0
                                         ---------   ---------
     Total Stockholders' deficit        (1,080,143) (  82,160)
                                         ---------   ---------
     Total Liabilities and Equity         (130,375)       721
                                         =========   =========


Shares Outstanding                       9,603,827  2,553,827


























<PAGE>

<PAGE>
<TABLE>



                  SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                        (A Development Stage Company)

                               UNAUDITED
                       STATEMENTS OF OPERATIONS
                      FOR THE THREE MONTHS AND SIX
                   MONTHS ENDED JUNE 30, 2000 AND 1999

<S>                               <C>            <C>              <C>           <C>

                                     Three Months Ended              Six Months Ended
                                     ------------------              ----------------
                                           June 30                        June 30
                                           -------                        -------
                                     2000           1999             2000          1999
                                     ----           ----             ----          ----
Revenues
 Consulting Services              $ 19,300       $       0        $ 19,300      $      0

Operating Expenses:
  Rent or Lease Expense              6,650               0         145,750             0
  Salaries and Wages Expense        26,500               0         598,495             0
  Equipment & Supplies Expense       4,839               0           6,939             0
  Interest Expense                  24,964               0         183,201             0
  Commissions and Fees Exp          21,965               0          30,965             0
  General and Administrative        24,604           8,571          48,863        17,142
                                  --------        --------       ---------      --------
     Total Expenses                109,522           8,571       1,014,213        17,142
                                  --------        --------       ---------      --------

Other Expenses:                          0               0               0             0

Net (loss)/Income                  (90,223)         (8,571)       (994,913)      (17,142)

Earnings per Common Share:
(Loss) from Operations Before
 Extraordinary items                 (0.01)         (0.01)
 (0.10)       (0.01)

Weighted-Average Number of Common
 shares Outstanding Used in Basic
 Earnings-per-Share calculation    9,603,827    2,553,827
9,603,827     2,553,827




</TABLE>
<PAGE>








              SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                     (A Development Stage Company)

                              UNAUDITED
                     STATEMENT OF CASH FLOWS
                   FOR THE THREE MONTHS ENDED
            JUNE 30, 2000 AND FOR THE THREE MONTHS
                     ENDING JUNE 30, 1999


                                  3 Months              3 Months
                                  Ended                 Ended
                                  June                  June
                                  30, 2000              30, 1999

Operating Activities:
  Net Loss                       $(90,223)            $  (8,571)

Adjustments to Reconcile Net
  Net Loss to Cash Used in
  Operating Activities
  Increase (Decrease) in:
   Inventory-Equipment             (50,465)                    0
   Notes Payable                    14,026                     0
   Due to related parties (note 5)  52,989                 8,571
   Extraordinary item-litigation         0                     0
                                   -------                ------
Cash Used in Operating Activities   16,549                     0
                                   -------                ------
Cash loss by Operating Activities  (73,674)                    0
                                   --------               ------

Cash Flows from Financing Activities
    Paid-in Capital                130,000                     0
    Rounding                             0                     0
                                   -------                ------
Cash used in Financing Activities  130,000                     0
                                   -------                ------
Net Increase (Decrease) in Cash     56,326                     0
                                    ======                ======

Summary Cash

   Beginning Cash                    6,133                   721
   Ending Cash                      62,460                   721
                                    ------                ======
 Net Increase (Decrease) in Cash    56,326                     0
                                    ======                ======


          STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
                     FOR THE YEAR ENDED 1999
               AND THE QUARTER ENDED June 30, 2000


                  Common Stock       APIC        Accumulated  Stockholder
                  Shares    Amount   Amount       (Deficit)   (Deficit)
                  -------------------------------------------------------

Balance December
31, 1999          2,553,827 $25,538  $7,777,260  $(7,975,670)  $(172,872)

 Issuance of shares
 first quarter    7,050,000 $70,500     409,000                  582,500

 Net loss
   1st Quarter                                     (  904,689)   (904,689)

Balance at
 March 31, 2000   9,603,827  96,038   8,286,260   (8,880,359)   (498,061)

 Net loss
   2nd Quarter                                     (   90,223)   ( 90,223)
                  --------- -------   ---------   ----------     -------
Balance at
 June 30, 2000    9,603,827  96,038   8,286,260   (8,970,582)   (588,284)



















<PAGE>

<PAGE>
Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
         FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THE COMPANY

Background.    Israel Semiconductor Corporation, as of March 31,
1999, had fully liquidated its only subsidiary and asset, GAD
Semiconductors, and was actively seeking new business ventures.  This
search resulted in the identification of SemcoLabs, Inc., a Florida
corporation and the then-represented business of testing restaurants
for bacterial safety, and a corporate combination agreement, executed
in September of 1999 and tentatively concluded in November of that
year.

Business Development.  The company, having originally entered into
the merger agreement in September of 1999, ultimately determined that
the consideration alleged to have been delivered in that agreement
was invalid and insufficient, and rescinded the agreement for share
issuance and corporate acquisition.  This resulted in the
cancellation of approximately 19,400,000 restricted common shares and
return of any assets and/or rights to SemcoLabs, Inc., the Florida
corporation, effective February 10, 2000.  Thereafter, in order to
preclude litigation claims by private investors that invested
$200,000 in Semcolabs (prior to any merger or acquisition by this
company), the company agreed to acquire $200,000 of Semco (Florida)
debt liability in exchange for the rights to Semco (Florida)'s wholly
owned subsidiary, Semco Bio-Vision, which basically contained certain
name trademark and tradename registrations and no other assets.  This
was accomplished in late February and resulted in the issuance of
2,650,000 shares of the company's common stock to satisfy the claims
of the $200,000 in liabilities absorbed with the Bio-Vision
acquisition.

Prior to that time, the company eliminated its then-existing
obligations to its legal counsel by the issuance of 150,000 shares of
restricted common stock, and obtained a minor amount of working
capital ($62,500) by selling 250,000 shares of restricted stock to
Mesa, Inc., in a private placement, which also included 250,000
warrants, exercisable at any time in the succeeding three years, at
an exercise price of $1.00 per share.

On February 15, 2000, the company approved a tentative exclusive sub-
license rights contract with Monaco Investment Group, Ltd., which was
in the process of securing the exclusive licensing rights for use of
the Merck Hi-Liter II technology in the United States, by pledging
$1,000,000 in orders.  Monaco agreed to license these rights to the
Company without any pre-commitment but with a dollar-derived minimum
purchase amount, measured on an annual basis.  The company agreed to
issue 4,000,000 shares of its restricted common stock to obtain a 5-
year exclusive sub-license of these rights in the United States so
long as certain minimum purchase requirements were met and Monaco
delivered the exclusive sub-license.  This did not occur until May of
2000.

The company also committed to repay certain loans made by an
officer/director of the company in the total amount of $1,060,867,
plus interest, or, alternatively, allowing a cancellation of the
indebtedness by conversion of the debt into company common stock at
the rate of $0.25 per share, this right to remain open for a period
of 5 years from the date of the agreement (March 28, 2000).  This
commitment to repay was entered into the first quarter's balance
sheet, resulting in a one-time loss of $904,689 recognized during
that reporting period.

Capital Resources and Liquidity.

During the Second Quarter, the company had total gross expenses of
$109.522, but also generated its first significant revenues from
provision of consulting services of $19,300, so the loss for the
quarter was only $90,223.  The Company should continue to receive
consulting income in the subsequent periods, but does not anticipate
sufficient revenues to offset losses prior to the end of the year.
Investors were being solicited for purposes of maintaining the
viability of the company, and a tentative deal with Girardi Financial
was executed on June 23, 2000, with a scheduled close during the
third quarter, pending satisfaction of certain preconditions.  In
full, this financing would result in approximately $500,000 in
additional sums available to the Company and provide the investors
with a conversion right ($0.25 per share), exercisable at some point
in the future, into common stock of the Company.

No other financing activity took place during this quarter.


Part II.  Other Information

     Item 1.   Legal Proceedings

               None

     Item 2.   Changes in Securities

               None

     Item 3.   Default Upon Senior Securities

               None

     Item 4.   Submission of Matters to a Vote of Security
                 Holders

               None

     Item 5.   Other Information

               None

     Item 6.   Exhibits and Reports

               None

     SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of
1934, Registrant has duly caused this Report to be signed on its
behalf by the undersigned, thereunto duly authorized.


                   SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                               (Registrant)


                              By:          /s/  Robert M. Terry
                                             Robert M. Terry,
                                             Chairman


Dated:  May 5, 2001